Research Article
Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases
Table 1
Clinical characteristics of analyzed groups of patients with AAA, AIOD, PRE, and HD.
| | Parameters | AAA (35 patients)
number (%) | AIOD (13 patients)
number (%) | PRE (50 patients)
number (%) | HD (34 patients)
number (%) |
| | Age (mean ± SD) | | | | | | Gender (male/female) | 26/9 | 9/4 | 27/23 | 23/11 | | Hypertension | 30 (85.7) | 8 (61.5) | 50 (100) | 34 (100) | | Hypercholesterolemia | 7 (20) | 3 (23) | 50 (100) | 34 (100) | | Coronary artery disease | 19 (54.3) | 7 (53.8) | 17 (34) | 34 (100) | | Previous myocardial infarction | 6 (17) | 2 (15.4) | 8 (16) | 9 (26.5) | | Cerebrovascular accident | 5 (14.3) | — | 1 (2) | 4 (11.8) | | Kidney disease | 6 (17) | 2 (15.4) | 50 (100) | 34 (100) | | Pulmonary disease | 4 (11.4) | 2 (15.4) | 0 | 0 |
| | Medications | | | | |
| | β-Blocker | 17 (48.6) | 7 (53.8) | 29 (58) | 20 (58.8) | | ACEI | 18 (51.4) | 5 (38.5) | 25 (50) | 11 (32) | | Statins | 18 (51.4) | 10 (77) | 39 (78) | 27 (79.4) | | NSAID | 35 (100) | 13 (100) | 40 (80) | 11 (32.4) |
|
|
